Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Abdominal | 2 | 2022 | 1248 | 0.180 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2022 | 1456 | 0.170 |
Why?
|
| Paclitaxel | 3 | 2011 | 1726 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2011 | 615 | 0.140 |
Why?
|
| Aneurysm, Ruptured | 1 | 2022 | 455 | 0.140 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 2219 | 0.130 |
Why?
|
| Reagent Strips | 1 | 2015 | 40 | 0.120 |
Why?
|
| Base Pairing | 1 | 2011 | 139 | 0.090 |
Why?
|
| Eosinophils | 1 | 2016 | 946 | 0.090 |
Why?
|
| Guanine | 1 | 2011 | 281 | 0.090 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 705 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 1739 | 0.080 |
Why?
|
| Nanoparticles | 2 | 2011 | 1966 | 0.080 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2016 | 921 | 0.080 |
Why?
|
| Mesothelioma | 2 | 2011 | 774 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 1086 | 0.080 |
Why?
|
| Albumins | 1 | 2010 | 578 | 0.070 |
Why?
|
| Mammography | 1 | 2016 | 2424 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2010 | 706 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 2513 | 0.050 |
Why?
|
| Genotype | 2 | 2015 | 13026 | 0.050 |
Why?
|
| DNA Damage | 1 | 2011 | 2462 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3238 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 2206 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4044 | 0.040 |
Why?
|
| Carcinoma | 1 | 2010 | 2311 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 21069 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 6360 | 0.040 |
Why?
|
| Tissue Embedding | 1 | 2015 | 43 | 0.030 |
Why?
|
| Paper | 1 | 2015 | 80 | 0.030 |
Why?
|
| Diamines | 1 | 2015 | 60 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2015 | 211 | 0.030 |
Why?
|
| Benzothiazoles | 1 | 2015 | 245 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 245 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2015 | 354 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2120 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 9373 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5379 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 13446 | 0.020 |
Why?
|
| Age Factors | 2 | 2018 | 18382 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2011 | 577 | 0.020 |
Why?
|
| Quinolines | 1 | 2015 | 769 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 938 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2022 | 24275 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 938 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6101 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2022 | 15802 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 13631 | 0.020 |
Why?
|
| Mastectomy | 1 | 2016 | 1848 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1927 | 0.020 |
Why?
|
| Disease Progression | 2 | 2016 | 13614 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4248 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 81537 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4882 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 22340 | 0.020 |
Why?
|
| Female | 7 | 2022 | 396141 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1966 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 17060 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3608 | 0.010 |
Why?
|
| Medicare | 1 | 2022 | 6815 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2022 | 65194 | 0.010 |
Why?
|
| Time Factors | 2 | 2018 | 40097 | 0.010 |
Why?
|
| Risk Factors | 2 | 2022 | 74850 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2530 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3604 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3940 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 8060 | 0.010 |
Why?
|
| Mass Screening | 1 | 2018 | 5449 | 0.010 |
Why?
|
| United States | 2 | 2022 | 72909 | 0.010 |
Why?
|
| DNA Repair | 1 | 2011 | 2048 | 0.010 |
Why?
|
| Aged | 3 | 2022 | 171163 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 59496 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15401 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3678 | 0.010 |
Why?
|
| Humans | 8 | 2022 | 765926 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5772 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 11196 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5745 | 0.010 |
Why?
|
| Base Sequence | 1 | 2011 | 12405 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10426 | 0.010 |
Why?
|
| Mice | 3 | 2011 | 81782 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8522 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4278 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 5450 | 0.010 |
Why?
|
| Animals | 3 | 2011 | 168735 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 22327 | 0.010 |
Why?
|
| Male | 2 | 2022 | 363815 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18292 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 223016 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54807 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 223088 | 0.000 |
Why?
|
Concepts
(91)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore